Soins; la revue de reference infirmiere最新文献

This text explores the impact of gender specificities on women's health at work, particularly in the hospital environment. It highlights the importance of adapting working conditions to take account of gynecological health risks, such as endometriosis, menopause and premenstrual syndrome. A dedicated consultation service, set up at the Brignoles-Le Luc intercommunal hospital center, helps to better understand and manage these risks, while improving employees' quality of life and working conditions.

In 2015, a dozen caregivers and agents from Nice's university hospital center came together in a group called "Health Promotion" to improve working conditions and the health of professionals. In 2024, this approach gained institutional recognition with the inauguration of the "Health Promotion for Healthcare Professionals" unit. Under the responsibility of the Public Health Department, this initiative brings together a multidisciplinary team to support projects proposed by the professionals themselves, and to co-construct solutions tailored to their needs, through concrete actions whose effectiveness is assessed on an ongoing basis.

Affecting nearly 10 million people in France, obesity is stigmatized. Based on social representations or general beliefs about weight regulation, this discrimination has both psychosocial and physiological consequences. Caregivers are not spared, and can just as easily be the victims of such prejudice as the perpetrators. To put an end to this stigmatization, it is first necessary to train healthcare professionals, who will then be in a position to offer better care to patients, and then to bring about change in society as a whole.

Experimented under Article 51, the "Espace médical nutrition et obésité" model is based on an innovative interdisciplinary and coordinated level 2 organization in the community, combining the gradation of obesity with the bundling of care pathways around digital solutions. The transition to enhanced coordinated care pathways aims to generalize this approach to facilitate access to care.

Faced with the exponential rise in the incidence of overweight and obesity, it's time to activate the state of health emergency. Significant and meaningful measures are urgently required. Responsibility for the obesity epidemic is a collective one, and must therefore unite political, educational and community players, as well as industry and the health sector, in an effort to improve the overall health of the population.

Nearly one in five adults in France live with an obesity. Obesity is a common and progressive disease, requiring prevention and care measures that include therapeutic patient education, as well as optimum coordination of the various players involved. There are many different players involved, depending on the level of complexity and severity of comorbidities and potential complications. Obesity is the typical model of chronic disease justifying expert support and assistance affecting all dimensions of care, coordination and training.

Bariatric surgery is indicated for patients with a body mass index ≥ 40 kg/m² or ≥ 35 kg/m² with comorbidities, after failure of conservative management. Its success relies on a multidisciplinary approach and personalized post-operative follow-up: control of reflux and mechanical complications for sleeve, in-depth nutritional assessment and management of malabsorption syndromes, dumping and undernutrition for bypass. Weight regain >10% of nadir weight warrants multidisciplinary reassessment.

Obesity is a chronic disease with multiple causes and serious complications. Treatments include lifestyle modifications and, for severe cases, medication. Today, molecules such as liraglutide and semaglutide are showing promising results in terms of weight loss and even cardiovascular benefits (for the latter), although reimbursement is limited in France. The dual agonist of glucagon-like peptide 1 and glucose-dependent insulinotropic peptide receptors (tirzepatide) also offers encouraging prospects. Research is continuing with bi- and tri-agonists to improve the management of obesity.